Why the study?
Due to the impact of atrial fibrillation on stroke-related mortality, further investigation into its molecular mechanisms is required.
Answers are grounded in this paper and cite their sources.
Metabolomic studies in atrial fibrillation consistently show alterations in energetic pathways, suggesting potential new molecular targets for understanding and treating the condition.
Atrial fibrillation involves an important type of heart arrhythmia caused by a lack of control in the electrical signals that arrive in the heart, produce an irregular auricular contraction, and induce blood clotting, which finally can lead to stroke. Atrial fibrillation presents some specific characteristics, but it has been treated and prevented using conventional methods similar to those applied to other cardiovascular diseases. However, due to the influence of this pathology on the mortality caused by cerebrovascular accidents, further studies on the molecular mechanism of atrial fibrillation are required. Our aim here is provide a compressive review of the use of metabolomics on this condition, from the study of the metabolic profile of plasma to the development of animal models. In summary, most of the reported studies highlighted alterations in the energetic pathways related to the development of the condition.
No takes yet. Share an insight, caveat, or question.
Arbeloa-Gómez et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: